Get the app!
Back to Trades

Adams Kendra

Chief Financial OfficerCIK 0001991929

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Across 2 filings between 2025–2026, Adams Kendra, Chief Financial Officer, has disclosed $41.8K in transactions — all concentrated in C4 Therapeutics, Inc. (CCCC). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Feb 18CCCC
C4 Therapeutics, Inc.
Adams KendraChief Financial OfficerGrant$32.6K
Sep 19CCCC
C4 Therapeutics, Inc.
Adams KendraChief Financial OfficerExercise$9.2K

2 filings